Generic Name: buprenorphine / naloxone
Common side effects of Suboxone include: constipation, diarrhea, headache, and nausea.  See below for a comprehensive list of adverse effects.
Applies to buprenorphine / naloxone: film, tablet
As well as its needed effects, buprenorphine / naloxone may cause unwanted side effects that require medical attention. 
If any of the following side effects occur while taking buprenorphine / naloxone, check with your doctor immediately:

If any of the following symptoms of overdose occur while taking buprenorphine / naloxone, get emergency help immediately:

Some buprenorphine / naloxone side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:


Applies to buprenorphine / naloxone: buccal film, sublingual film, sublingual tablet
The most commonly observed adverse events included headache, nausea, vomiting, hyperhidrosis, constipation, signs and symptoms of withdrawal, insomnia, pain and peripheral edema.  Additionally, oral hypoesthesia was reported with the sublingual film.[Ref]
Very common (10% or more): Pain (22.4%) Common (1% to 10%): Asthenia, chills, pyrexia, malaise, injury, ear painUncommon (0.1% to 1%): Hypothermia, heat strokePostmarketing reports: Vertigo[Ref]
Very common (10% or more): Headache (36.4%) Common (1% to 10%): Migraine, dizziness, hypertonia, paraesthesia, somnolenceUncommon (0.1% to 1%): Amnesia, convulsion, hyperkinesia, speech disorder, tremor Buprenorphine:Postmarketing reports: Neonatal withdrawal syndrome including symptoms of hypertonia, neonatal tremor, neonatal agitation, and myoclonus; reports of neonatal convulsions, apnea, respiratory depression, and bradycardia[Ref]
Buprenorphine-naloxone:Common (1% to 10%): Pharyngitis, rhinitis, cough, sinusitis, upper respiratory infection, asthma, bronchitis, dyspnea, pneumonia, increased sputumUncommon (0.1% to 1%): YawningFrequency not reported: RhinorrheaBuprenorphine:Frequency not reported: Significant respiratory depression, coma, death[Ref]
There have been postmarketing reports coma and death associated with concomitant use of buprenorphine and benzodiazepines; many of these reports have involved misuse by self-injection.[Ref]
Very common (10% or more): Constipation (12.1%), nausea (15%), abdominal pain (11.2%)Common (1% to 10%): Vomiting, diarrhea, dyspepsia, flatulence, oral hypoesthesiaUncommon (0.1% to 1%): Mouth ulceration, tongue discoloration, tooth abscess, glossodynia, mucosal erythema (oral), toothacheFrequency not reported: Stomach discomfort, Postmarketing reports: Stomatitis, glossitis, tongue disorder, pancreatitis[Ref]
Common (1% to 10%): Erectile dysfunction, decreased libidoUncommon (0.1% to 1%): Amenorrhea, ejaculation disorder, menorrhagia, metrorrhagiaPostmarketing reports: Disorders of pregnancy[Ref]
Buprenorphine: Frequency not reported: Hypersensitivity reactions including bronchospasm, angioneurotic edema, and anaphylactic shock; more commonly reported as rash hives, and pruritusNaloxone: Frequency not reported: Hypersensitivity reactions including bronchospasm, angioneurotic edema, and anaphylactic shock; more commonly reported as rash hives, and pruritus[Ref]
Common (1% to 10%): Vasodilation, hypertensionUncommon (0.1% to 1%): Angina pectoris, bradycardia, myocardial infarction, palpitations, tachycardia, hypotension, chest painPostmarketing reports: Peripheral edema, syncope, orthostatic hypotension, heart rate and rhythm disorders[Ref]
Common (1% to 10%): Amblyopia, lacrimal disorderUncommon (0.1% to 1%): Conjunctivitis, miosis[Ref]
Buprenorphine-naloxone: Common (1% to 10%): Abnormal liver function testsBuprenorphine: Frequency not reported: Cytolytic hepatitis, hepatitis with jaundice, transient asymptomatic elevations of hepatic transaminases, hepatic failure, hepatic necrosis, hepatorenal syndrome, and hepatic encephalopathy.[Ref]
In clinical trials and in postmarketing reports, cases of cytolytic hepatitis and hepatitis with jaundice have been reported in association with buprenorphine use.  The spectrum of abnormalities has ranged from transient asymptomatic elevations of hepatic transaminases to hepatic failure, hepatic necrosis, hepatorenal syndrome, and hepatic encephalopathy.  The presence of preexisting liver enzyme abnormalities, viral hepatitis, concomitant hepatotoxic drug use, and ongoing IV drug abuse may have played a causative or contributory role.[Ref]
Common (1% to 10%): Anxiety, depression, nervousness, abnormal thinkingUncommon (0.1% to 1%): Abnormal dreams, agitation, apathy, depersonalization, drug dependence, euphoric mood, hostilityFrequency not reported: Restlessness, irritabilityPostmarketing reports: Hallucination, attempted suicide, insomnia[Ref]
Very common (10% or more): Sweating (14%)Common (1% to 10%): Pruritus, rash, urticaria, ecchymosisUncommon (0.1% to 1%): Acne, alopecia, dermatitis exfoliative, dry skin, skin mass, herpes simplex, skin noduleFrequency not reported: Piloerection, cold sweat[Ref]
Common (1% to 10%): Urine abnormalityUncommon (0.1% to 1%): Urinary tract infection, vaginal infection, albuminuria, dysuria, hematuria, urinary retention[Ref]
Uncommon (0.1% to 1%): Anemia, leucocytosis, leukopenia, lymphadenopathy, thrombocytopenia[Ref]
Common (1% to 10%): Influenza, infection[Ref]
Uncommon (0.1% to 1%): Decreased appetite, hyperglycemia, hyperlipidemia, hypoglycemia, decreased weight[Ref]
Common (1% to 10%): Back pain, arthralgia, muscle spasms, myalgia, rigid neck, leg cramps, joint disorderUncommon (0.1% to 1%): ArthritisFrequency not reported: Arthralgia[Ref]
Uncommon (0.1% to 1%): Nephrolithiasis, blood creatinine increased[Ref]
1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
2. "Product Information. Bunavail (buprenorphine-naloxone)." BioDelivery Sciences International, Inc., Raleigh, NC. 
3. Cerner Multum,  Inc. "Australian Product Information." O 0
4. "Product Information. Subutex (buprenorphine)." Reckitt and Colman Pharmaceuticals Inc, Richmond, VA. 
5. "Product Information. Zubsolv (buprenorphine-naloxone)." Orexo US, Inc, New York City, NY. 
It is possible that some side effects of Suboxone may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

Cough or hoarseness
feeling faint, dizzy, or lightheaded
feeling of warmth or heat
fever or chills
flushing or redness of the skin, especially on the face and neck
headache
lower back or side pain
painful or difficult urination
sweating


Bloating or swelling of the face, arms, hands, lower legs, or feet
rapid weight gain
tingling of the  hands or feet
unusual weight gain or loss


Blurred vision
confusion
difficult or troubled breathing
dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
drowsiness
irregular, fast, slow, or shallow breathing
pale or blue lips, fingernails, or skin
pinpoint pupils
relaxed and calm feeling
sleepiness
unusual tiredness or weakness


Abdominal or stomach pain
difficulty having a bowel movement (stool)
lack or loss of strength
nausea
pain
trouble sleeping
vomiting


Back pain
diarrhea
runny nose
sneezing
stuffy nose

